Dld Asset Management, LP Biocryst Pharmaceuticals Inc Transaction History
Dld Asset Management, LP
- $632 Million
- Q1 2025
A detailed history of Dld Asset Management, LP transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Dld Asset Management, LP holds 359,600 shares of BCRX stock, worth $3.7 Million. This represents 0.11% of its overall portfolio holdings.
Number of Shares
359,600Holding current value
$3.7 Million% of portfolio
0.11%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding BCRX
# of Institutions
293Shares Held
177MCall Options Held
721KPut Options Held
489K-
Vanguard Group Inc Valley Forge, PA21.7MShares$223 Million0.0% of portfolio
-
Black Rock Inc. New York, NY20MShares$205 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ8.93MShares$91.9 Million5.64% of portfolio
-
Avoro Capital Advisors LLC New York, NY8.7MShares$89.5 Million1.06% of portfolio
-
State Street Corp Boston, MA7.81MShares$80.4 Million0.0% of portfolio
About BIOCRYST PHARMACEUTICALS INC
- Ticker BCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,944,992
- Market Cap $1.91B
- Description
- BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...